Owing to the mediating role of HSPB1 in RTN3‐driven cardiac dysfunction, we determined whether pharmacological inhibition of HSPB1 could counteract the protective effects of RTN3 knockout on HF after MI. Here, HSPB1 is linked to myocardial infarction.